PATENT CLAIM ANALYSIS

Application Number: 16164929
Application Type: Utility
Filing Date: 2018-10
Publication Date: 2019-02
Patent Classification: ["514", "064000"]

Abstract:
A beta-lactamase inhibitor having a formula (I). Also provided is a method of using the beta-lactamase inhibitor for prevention or treatment of diseases.

Claim (Index 3):
The compound of  claim 1 , wherein the compound is:

Metadata:
- Claim Count in Document: 1.0
- Percentile: 97.0
- Lexical Diversity: 1.22727
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: True
- Related Applications: ['15162395', '15675253', '15435097', '14773717', '15922376']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7781197493511156
- 35 USC 102 Novelty (BERT): 0.4954246197594309
- Combined Prediction Score: 0.7498502363919473
- Mean Citation Score: 235.779214
- Max Citation Score: 238.2742
- Similarity Product: 179.81909212328196

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test